The appointment is effective from 1 October 2025.
Dr. Noelia Ferruz collaborates with Integra Therapeutics and UPF in new research
Dr. Nick Stroustrup received 250 thousand euro grant to lead the project
Study hints at a one-drug-per-protein rather than one-drug-per-mutation strategy to treat rare disease
qGenomics was founded in 2008 by CRG and UPF researchers
Funding will help understand how cells delete messages for ‘bad proteins’ and how to build mature human brain cells on demand
Translocations cause bigger ripple effects than previously thought, according to study of mantle cell lymphoma
Highest-resolution essentiality map created for any living cell to date can greatly accelerate development of ‘living medicines’
Discovery reveals a new druggable foothold against common type 2 diabetes and a rare early onset form
